Home  »  Remus Pharmaceuticals Ipo

Let’s have a detailed review of the company and analytics of the Remus Pharmaceuticals IPO release date, IPO offer price, subscription, Remus Pharmaceuticals Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.

Face Value Rs 10
Price Band Rs 1150 to Rs 1229
Listing At NSE, SME
Min. Order Quantity 100 Shares
Listing Date 29 May 2023
Offer for Sale Rs Lakh
Fresh Issue Rs 4,769 Lakh
IPO Size Rs 4,769 Lakh
Tick Size 1

Remus Pharmaceuticals IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.

Live Performance – Remus Pharmaceuticals Share Price

Remus Pharmaceuticals IPO – Summary

Remus Pharmaceuticals IPOTheir Company was originally incorporated as ‘Remus Pharmaceuticals Private Limited’ as a private limited company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated September 21, 2015.

It is issued by the Assistant Registrar of Companies, Gujarat. Later on, pursuant to a special resolution passed by their shareholders in the Extra-Ordinary General Meeting held on January 02, 2023.


Remus Pharmaceuticals IPO Date

The opening and closing dates of Remus Pharmaceuticals IPO are 17 May 2023 and 19 May 2023 respectively.

Remus Pharmaceuticals IPO Subscription

Day / Date QIB NII RII Total Subscription
1st Day – 17th May 0.00x 2.85x 2.85x 1.43x
2nd Day –  18th May 1.48x 12.25x 10.93x 6.41x
3rd Day – 19th May 10.75x 229.31x 49.81x 57.21x
Shares Offered or Net Issue 138,750 41,625 97,125 277,500

The shares subscribed by the public will be updated here.

Remus Pharmaceuticals IPO Allotment Status

Here, you can find the Allotment Status of this IPO.

Allotment of Equity Shares are pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.

Remus Pharmaceuticals Limited IPO Listing Date

Find the dates below on the basis of allotment, refund, listing, and more:

Basis of Allotment Finalization 24 May 2023
Refunds Initiation 25 May 2023
Credit of Shares to Demat Account 26 May 2023
Share Listing Date 29 May 2023

Remus Pharmaceuticals IPO Price Band

The face value of each share is Rs.10, but the price band of the IPO is Rs 1150 to Rs 1229 

Remus Pharmaceuticals IPO Equity Size

This Initial Public Issue of 388,000 Equity Shares of Rs.10 each for cash at a price of Rs 1150 to Rs 1229 per equity share aggregating to Rs.4,769 Lakh.

Remus Pharmaceuticals IPO Share Offering

Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of 388,000 Equity Shares of Rs.10/ each.

Issue Size: 388,000 Equity Shares of Rs.10 each, aggregating to Rs.4,769 Lakh

Open Free Demat Account Now!

    Fill Your Details Here
    1. Open Demat AccountInvest in IPO

    Remus Pharmaceuticals IPO – Live Performance

    The listing date of this IPO is 29 May 2023. You can check the live performance of the IPO here, only after it is listed on exchanges.

    Live IPO Performance – Remus Pharmaceuticals Share Price

    Remus Pharmaceuticals IPO Grey Market Premium

    The Remus Pharmaceuticals Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is Rs X. 

    Remus Pharmaceuticals IPO – Company Overview

    Their company is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. Their company also deals in API (Active Pharmaceutical Ingredient).

    They also provide technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries.

    Having cultivated strong and dependable customer relationships ranging from Generic distributors, regional distributors and Multinational distributors to Hospitals and Clinics through a responsive distribution network, their clients are spread in more than 20 countries.

    They look forward to forming long-lasting relationships that enhance the lives of their patients. Their Company is majorly engrossed in the pharmaceutical business involving marketing, trading and distribution of a wide range of pharmaceutical finished formulations and products, manufactured under loan license and/or contract manufacturing.

    Remus Pharmaceuticals IPO – Financial Statements

    A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:

    Financial Summary:

    Amount (in INR & Lakh)
    31-Dec-22 31-Mar-22 Mar-21 31-Mar-20
    Total Assets 3,352.96 1,590.93 1,104.96 530.36
    *Total Revenue 3,361.19 2,543.71 1,922.45 1,276.89
    Total Expense 2,491.86 2,088.84 1,786.64 1,167.49
    Profit After Tax 643.89 338.57 102.58 81.16

    Earnings per Equity Share (in Lakh)

    31-Dec-22 31-Mar-22 Mar-21 31-Mar-20
    Basic & Diluted 64.35 33.86 10.26 8.12

    Further, their PAT for the period ended on Dec 31, 2022, March 31, 2022, March 31, 2021, and March 31, 2020, were Rs. 643.89 Lakh, Rs. 338.57 Lakh, Rs. 102.58 Lakh and Rs. 81.16 Lakh respectively.

    Remus Pharmaceuticals IPO – Promoters

    The Promoter of this company is:


    List of Related Parties (Key Managerial Personnel)

    • Arpit Deepak Kumar Shah – Managing Director
    • Swapnil Jatinbhai Shah – Chairman and Whole Time Director
    • Roma Vinodbhai Shah – Whole Time Director
    • Anar Swapnil Shah – Whole Time Director
    • Balwant Purohit – Independent Director
    • Sanjana Sanjeev Shah – Independent Director
    • Vishrut Chandramauli Pathak – Independent Director

    Remus Pharmaceuticals IPO – Promoters Holding

    • Pre-Issue Share Holding – %
    • Post-Issue Share Holding – %

    Remus Pharmaceuticals IPO Offer Details or Issue Details

     Particulars  No. Of Equity Shares
     Equity Shares Offered  Up to X Equity Shares aggregating up to Rs.[●] Lakh
    of which:
    Issue Reserved for the Market Makers Up to [●] Equity Shares aggregating up to Rs.[●]
    Net Issue to the Public Up to [●] Equity Shares aggregating up to Rs.[●]
    Of which:
    Retail Investors Portion Not less than [●] Equity Shares
    Other than Retail Individual Investors Not more than [●] Equity Shares
     Equity Shares outstanding prior to the Issue X Equity Shares
     Equity Shares outstanding after the Issue X Equity Shares

    Remus Pharmaceuticals IPO Issue Object

    Their Company proposes to utilize the Net Proceeds towards funding the following objects:

    1. To Meet Working Capital Requirements
    2. Funding investments for acquisitions and general corporate purposes
    3. To meet Public Issue Expenses

    Remus Pharmaceuticals IPO – Business Strategy

    • Improve global presence
    • Leveraging their market skills and relationship
    • To increase brand visibility
    • Maintaining an edge over competitors
    • Customer Satisfaction

    Remus Pharmaceuticals IPO – Basis of Offer Price

    The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

    Qualitative factors are:

    • Experienced Promoters and Management Team
    • Wide range of Products
    • Strategic Location of Contract Manufacturing Facilities
    • Diversified business operations and revenue base
    • Scalable Business Model

    The relevant quantitative factors are:

    Basic & Diluted EPS RONW (%) NAV (Rs.)
    31-Mar-22 33.86 52.64 64.32
    31-Mar-21 10.26 33.68
    Mar-20 8.12 40.17

    Remus Pharmaceuticals IPO: Competitive Peers

    Face Value (Rs.) P/E EPS  (Rs.) Return on Net Worth (%) Revenue from Operation (Rs. in Lakhs)
    Remus Pharmaceuticals Limited 10 [●] 33.86 52.64 2471.71
    Listed Peers
    Trident Lifeline Limited 10 21.46 6.92 82.66 2176.80
    Vaishali Pharma Limited 10 42.68 3.82 15.27 7153.68
    Chandra Bhagat Pharma Limited 10 99.06 1.06 2.99 9407.56

    Remus Pharmaceuticals IPO Lead Managers

    Lead Managers
    SEBI Registration Number: INM000012917
    Address: 807, Phoenix, Opp. Girish Cold Drinks, Near Vijay Cross Roads, Navrangpura,
    Ahmedabad -380009, Gujarat.
    Telephone Number: 079 4840 5357
    Email Id: mb@beelinemb.com
    Investors Grievance Id: ig@beelinemb.com
    Website: www.beelinemb.com
    Contact Person: Mr. Nikhil Shah
    CIN: U67190GJ2020PTC114322

    Remus Pharmaceuticals IPO Registrar to offer

    Registrar to the Offer
    SEBI Registration Number: INR000004058
    Address: C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai,
    Maharashtra, India – 400 083.
    Tel. Number: +91 810 811 4949 Fax- +91 22 4918 6195
    Email Id: remuspharmaceuticals.ipo@linkintime.co.in
    Investors Grievance Id: remuspharmaceuticals.ipo@linkintime.co.in
    Website: www.linkintime.co.in
    Contact Person: Shanti Goapalkrishnan
    CIN: U67190MH1999PTC118368

    Remus Pharmaceuticals IPO – Other Details

    • Statutory Auditor – M/s. Parikh & Majmudar, Chartered Accountants
    • Legal Counsel to the Company – M V KINI, LAW FIRM
    • Bankers to the Company –  ICICI Bank Limited

    Remus Pharmaceuticals IPO Review by Stock Brokers

    Top Stock Brokers Review Company Reputation Competitive Edge Financial Statement Popularity Index Promoters Reputation
    Angel Broking 7.5/10 7.4/10 8.5/10 8.1/10 7.1/10
    Sharekhan 7.2/10 7.1/10 8.6/10 8.1/10 7.2/10
    Kotak Securities 7.3/10 7.5/10 8.4/10 8.1/10 7.3/10
    ICICI Direct 7.3/10 7.3/10 8.7/10 8.1/10 7.1/10
    IIFL 7.5/10 7.2/10 8.8/10 8.0/10 7.1/10
    Edelweiss 7.5/10 7.4/10 8.4/10 8.3/10 7.2/10
    Zerodha 7.4/10 7.1/10 8.5/10 8.1/10 7.0/10
    5Paisa 7.1/10 7.1/10 8.4/10 8.1/10 7.1/10
    Karvy 7.4/10 7.3/10 8.2/10 8.1/10 7.1/10
    Motilal Oswal 7.1/10 7.1/10 8.6/10 8.3/10 7.2/10


    Subscribe to Remus Pharmaceuticals IPO

      Fill Your Details Here
      1. Open Demat AccountInvest in IPO

      Remus Pharmaceuticals Limited IPO News

      News 1 – IPO DRHP Download

      News 2 – IPO RHP Prospectus Download

      Remus Pharmaceuticals IPO Review FAQs

      Check out various FAQs related to Remus Pharmaceuticals IPO:

      What is the Issue Size of Remus Pharmaceuticals IPO?

      The Company is making an initial public offer of 388,000 equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.

      What is the Price band of Remus Pharmaceuticals IPO?

      The price band for this particular IPO ranges between Rs 1150 to Rs 1229. As far as the face value of the share is of concern, it is Rs. 10 per share.

      What is the Remus Pharmaceuticals IPO Open Date?

      The opening and closing dates for this IPO have been updated. The IPO is set to open on 17 May 2023, while the closing date is set for 19 May 2023.

      What is the Remus Pharmaceuticals IPO Allotment Date?

      They also have the news regarding the respective allotment dates of this IPO. The basis of Allotment finalization is on 24 May 2023, refund initiation is on 25 May 2023, credit of shares is on 26 May 2023, and share listing date is on 29 May 2023.

      What is the Remus Pharmaceuticals IPO Listing Date?

      Shares of this company shall be listed in the exchanges on 29 May 2023. The date, when the listing would be done, is stagnant on 29 May 2023.

      Who is the Registrar of Remus Pharmaceuticals IPO?

      One of the reputed registrars is managing the issue of this IPO, i.e. LINK INTIME INDIA PRIVATE LIMITED. Their website will help you regarding the further information you are on the lookout for.

      Who is the Promoter of Remus Pharmaceuticals IPO?

      Here are the promoters of this IPO – MR. ARPIT DEEPAKKUMAR SHAH, MS. ROMA VINODBHAI SHAH, MR. SWAPNIL JATINBHAI SHAH AND MRS. ANAR SWAPNIL SHAH. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.

      What is the GMP of Remus Pharmaceuticals IPO?

      They have obtained the GMP of this IPO and it is Rs NA. Further insights into the Kostak rate and subject to sauda or SS are as well included in this report.

      Is Remus Pharmaceuticals IPO Good for Investment?

      They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.

      What is the PAT of Remus Pharmaceuticals Company?

      They have the information on company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2022 in Lakh is 338.57, 2021 is 102.58, and 2020 is 81.16. PAT from Dec 2022 is 643.89.

      Calculate your return on investment!

      Asset Class ROI (Rs.) Profit (Rs.) Profit (%)
      Real Estate
      Fixed Deposit
      Mutual Fund

      Featured Topics


      Get 100% IPO Allotment Guarantee! Subscribe to IPO